✦ LIBER ✦

Cisplatin-based chemotherapy changes the incidence of bilateral testicular cancer

✍ Scribed by Jean-Paul A. van Basten; Harald J. Hoekstra; Mels F. van Driel; Dirk Th. Sleijfer; Jos H. J. Droste; Heimen Schraffordt Koops

Publisher: Springer
Year: 1997
Tongue: English
Weight: 734 KB
Volume: 4
Category: Article
ISSN: 1068-9265
DOI: 10.1007/bf02303585

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advanced ovarian cancer in the elderly:

Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy

✍ Silvana Chiara; Rita Lionetto; Maura Vincenti; Milena Bruzzone; Maria Teresa Nob 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 85 KB

From 1982 through 1996, 547 untreated advanced ovarian cancer patients were entered onto Gruppo Oncologico Nord-Ovest (GONO) consecutive randomized trials including cisplatin-based chemotherapy. End points of analysis included the influence of age on prognosis, toxicity, clinical/surgical response r

The incidence, prognosis, clinical and h

The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary

✍ Lajos Géczi; Frederic Gomez; Mihály Bak; István Bodrogi 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 194 KB

Cisplatin-based chemotherapy: the only a

Cisplatin-based chemotherapy: the only alternative in chemoradiation of head and neck cancer? Experience of the Institute of Oncology, Ljubljana, Slovenia

✍ Primož Strojan 📂 Article 📅 2007 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 127 KB

Predictive factors of response to cispla

Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer

✍ Lisa Sengeløv; Claus Kamby; Poul Geertsen; Lisbeth Juhler Andersen; Hans von der 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 108 KB

Incidence of chemotherapy-induced amenor

Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens

✍ José Alejandro Pérez-Fidalgo; Susana Roselló; Elisa García-Garré; Esther Jordá; 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 206 KB

The benefit of cisplatin-based polychemo

The benefit of cisplatin-based polychemotherapy for adenocarcinoma of the lung

✍ The Kyushu Lung Cancer Chemotherapy Study Group; Nobuyuki Hara; Mitsuo Ohta; Yoi 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 426 KB